What we offer

Clinical development services for decisions that must hold

Service gateway

Choose the mandate

Each entry point connects a defined decision or execution problem to senior ownership, concrete outputs and the appropriate delivery model.

Seven MB&P service entry points connected to one clinical-development system without fragmented accountability.

Accountable CMO-level judgment for clinical strategy, board alignment and execution governance.

Explore this mandate →

Evidence architecture, endpoint logic, estimands, feasibility and pivotal readiness.

Explore this mandate →

Restore signal integrity, feasibility realism and execution control before decision value is lost.

Explore this mandate →

Align approval, payer relevance and evidence generation before requirements diverge.

Explore this mandate →

Clinical risk maps, value gates and fundable development plans that withstand technical diligence.

Explore this mandate →

Connect scientific narrative, evidence strategy, external insight and adoption credibility.

Explore this mandate →

Governed global execution through Verum and qualified local reach through NECTAR.

Explore this mandate →

Problems we solve

Recognize the failure mode

The development thesis is unclear

The program lacks one testable logic connecting mechanism, population, evidence and future value.

Pivotal choices do not align

Endpoints, estimands, comparator, duration, feasibility and payer relevance pull in different directions.

The trial is losing control

Recruitment, site behavior, vendor performance, quality signals or governance threaten the readout.

Senior medical ownership is missing

Critical decisions are diffused across functions, advisors and vendors without one accountable owner.

The asset is difficult to finance

Clinical risk, use of proceeds and value-inflection milestones are not explicit enough for diligence.

Evidence does not translate

Medical Affairs, HEOR, RWE and market access remain downstream from development strategy.

How we engage

Match the engagement structure to the work

From ad-hoc senior advice to Fractional CMO leadership and full clinical-trial project delivery, the commercial and governance model scales with the work.

One-stop operating model

Use one entry point or connect the full development path

The seven services are entry points, not silos. A mandate can begin with one decision and expand only where the interfaces create material risk. Clinical strategy, regulatory and payer evidence, fundraising readiness, Medical Affairs and operational execution remain connected through one governance logic.

  • One accountable clinical architecture across functions
  • Fundraising and partnering readiness embedded in the development path
  • Verum as the sponsor-facing execution spine
  • NECTAR local depth where it improves speed, access or regulatory fluency
Medical, regulatory, payer, capital and execution perspectives converging into one integrated clinical-development decision system.

A decision-grade next step

Start with the problem, not a generic scope.

We will identify the right level of ownership and the shortest credible path to a decision.